Table 3. Multivariate analysis of prognostic factors and EFS and OS for gastric ‘pure' DLBCL patients.
| Characteristics |
EFS |
OS |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P-value | HR | 95% CI | P-value | |
| HP status | ||||||
| Negative vs positive | 2.509 | 1.279–4.924 | 0.007 | 2.666 | 1.279–5.553 | 0.009 |
| Age (years old) | ||||||
| ⩾60 vs <60 | 1.559 | 0.785–3.096 | 0.204 | 1.639 | 0.779–3.450 | 0.193 |
| Stage | ||||||
| IIE2/III/IV vs I-IIE1 | 2.174 | 0.854–5.533 | 0.103 | 3.9 | 1.451–10.479 | 0.007 |
| ECOG | ||||||
| ⩾2 vs 0–1 | 2.867 | 1.350–6.088 | 0.006 | 4.308 | 1.872–9.917 | 0.001 |
| LDH | ||||||
| High vs normal | 1.754 | 0.538–5.714 | 0.351 | 1.755 | 0.366–8.406 | 0.482 |
| IPI risk group | ||||||
| ⩾2 vs 0–1 | 1.139 | 0.296–4.379 | 0.849 | 1.306 | 0.244–6.998 | 0.755 |
Abbreviation: CI, confidence interval; DLBCL, diffuse large B-cell lymphoma; ECOG, Eastern Cooperative Oncology Group; EFS, event-free survival; HP, H. pylori; HR, hazard ratio; IPI, International Prognostic Index; LDH, lactate dehydrogenase; OS, overall survival.